CERIANNA

Peak

fluoroestradiol f 18

NDAINTRAVENOUSSOLUTION
Approved
May 2020
Lifecycle
Peak
Competitive Pressure
30/100

Mechanism of Action

Positron Emitting Activity

Pharmacologic Class:

Radioactive Diagnostic Agent

Indications (1)

breast cancer
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers